Trial intelligence / Profile preview

Effects of 17β-estradiol on Muscle Mass During Immobilization

NCT03069781Phase 1Withdrawn

Sponsor
McMaster University
Start
May 2017
Primary completion
May 2018
Modality
Hormone, Biologic
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in muscle atrophy comparing 17β-estradiol with Placebo (2 arms). Primary endpoint: Muscle protein synthesis and breakdown rates. Planned start May 2017; status: withdrawn.

02

Drugs

estradiol
03

Conditions

muscle atrophy

Beyond the preview

Go deeper on NCT03069781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03069781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call